Effector systems involved in the insulin secretory responses to efaroxan and RX871024 in rat islets of Langerhans

European Journal of Pharmacology

Volumn 350, Issue 2-3, 1998, Pages 251-258

  Mourtada, Mirna ^a   Smith, Stephen A ^b   Morgan, Noel G ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

cAMP; Imidazoline receptor; Insulin secretion; Islet of Langerhans; K+ channel; Protein kinase

Indexed keywords

1 PHENYL 2 (IMIDAZOLIN 2 YL)BENZIMIDAZOLE; CALCIUM CHANNEL; CYCLIC AMP DEPENDENT PROTEIN KINASE; EFAROXAN; IMIDAZOLINE DERIVATIVE; POTASSIUM CHANNEL; PROTEIN KINASE C; RX 871024; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL MEMBRANE; DOSE RESPONSE; EXTRACELLULAR CALCIUM; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BENZOFURANS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CYCLIC AMP; DOWN-REGULATION; ENZYME INHIBITORS; IMIDAZOLES; INDOLES; INSULIN; ISLETS OF LANGERHANS; MALE; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR;

EID: 0032486149     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00245-3     Document Type: Article

References (28)

1. Berdeu D., Gross R., Ribes G., Loubatieres-Mariani M.-M., Bertrand G. Effects of imidazolines and derivatives on insulin secretion and vascular resistance in perfused rat pancreas. Eur. J. Pharmacol. 254:1994;119-125.
2. Berdeu D., Puech R., Ribes G., Loubatieres-Mariani M.-M., Bertrand G. Antazoline increases insulin secretion and improves glucose tolerance in rats and dogs. Eur. J. Pharmacol. 324:1997;233-239.
3. Brackeen M.F., Cowan D.J., Stafford J.A., Schoenen F.J., Veal J.M., Domanico P.L., Rose D., Strickland A.B., Verghese M., Feldman P.L. Design and synthesis of conformationally constrained analogues of 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one (Ro-201724) as potent inhibitors of cAMP-specific phosphodiesterase. J. Med. Chem. 38:1995;4848-4854.
4. 2-adrenoceptors and imidazoline binding sites in the control of insulin secretion. Clin. Sci. 85:1993;671-677.
5. + channels. Eur. J. Pharmacol. 176:1990;97-101.
6. ATP channels in insulin-secreting cells. Eur. J. Pharmacol. 204:1991;41-48.
7. Dostmann W.R.G., Taylor S.S. Identifying the molecular switches that determine whether Rp-cAMP-S functions as an antagonist or agonist in the activation of cAMP-dependent protein kinase I. Biochemistry. 30:1991;8710-8716.
8. + channels by phentolamine and other alpha-adrenoceptor antagonists. Br. J. Pharmacol. 103:1991;1847-1850.
9. Gadbois D.M., Crissman H.A., Tobey R.A., Bradbury E.M. Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells. Proc. Natl. Acad. Sci. USA. 89:1992;8626-8630.
10. + channels in mouse B cells. J. Clin. Invest. 91:1993;871-880.
11. Gey G.O., Gey M.K. Maintenance of human normal cells in continuous culture: preliminary report. Cultivation of mesoblastic tumors normal cells and notes on methods of cultivation. Am. J. Cancer. 27:1936;45-76.
12. Hughes, S.J., Ashcroft, S.J.H., 1992. Cyclic AMP, protein phosphorylation and insulin secretion. In: Flatt, P.R. (Ed.), Nutrient Regulation of Insulin Secretion. Portland Press, UK, p. 271.
13. + channels insulinotrophic action by the antiarrhythmic agent, cibenzoline. Br. J. Pharmacol. 117:1996;1749-1755.
14. + channels in pancreatic-cells. Br. J. Pharmacol. 107:1992;8-14.
15. Kobayashi E., Nakano H., Morimoto M., Tamaoki T. Calphostin C, a novel microbial compound, is a highly potent specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:1989;548-553.
16. Michel A., Laurent F., Chapat J.P., Boucard M., Bonnet P.A. Pharmacological activities of imidazo(1,2-alpha)pyrazine derivatives. Arnzeimittelforschung. 45:1995;1288-1293.
17. Molderings G.J. Imidazoline receptors: basic knowledge, recent advances and future prospects for therapy and diagnosis. Drugs Future. 22:1997;757-772.
18. Montague W., Taylor K.W. Pentitols and insulin release by isolated rat islets of Langerhans. Biochem. J. 109:1968;333-339.
19. Morgan N.G., Chan S.L.F., Brown C.A., Tsoli E. Characterization of the imidazoline binding site involved in regulation of insulin secretion. Ann. N.Y. Acad. Sci. 763:1995;361-373.
20. Persaud S.J., Jones P.M., Sugden D., Howell S.L. The role of protein kinase C in cholinergic stimulation of insulin secretion from rat islets of Langerhans. Biochem. J. 264:1989;753-758.
21. Persaud S.J., Jones P.M., Howell S.L. Activation of protein kinase C is not required for glyceraldehyde-stimulated insulin secretion from rat islets. Biochim. Biophys. Acta. 1095:1991;183-185.
22. + channels in mouse pancreatic β-cells. Br. J. Pharmacol. 101:1990;115-120.
23. ATP channels is mediated by Kir6.2. Proc. Natl. Acad. Sci. USA. 94:1997;11716-11720.
24. + channels in pancreatic B-cell. Exp. Clin. Endocrinol. 103:1995;42-45.
25. Schulz A., Hasselblatt A. Phentolamine, a deceptive tool to investigate sympathetic nervous control of insulin release. Naunyn-Schmiedeberg's Arch. Pharmacol. 337:1988;637-643.
26. Sharp G.W.G. The adenylate cyclase-cAMP system in islets of Langerhans: its role in the control of insulin release. Diabetologia. 16:1979;287-296.
27. 2+ by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release. Br. J. Pharmacol. 119:1996;911-916.
28. ATP channels and interaction with the exocytotic machinery. Diabetes. 45:1996;1610-1618.